BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18802333)

  • 21. PTD-hFOXP3 protein acts as an immune regulator to convert human CD4(+)CD25(-) T cells to regulatory T-like cells.
    Liu X; Xu X; Lin X; Tian Y; Ji B; Xia S; Xu S; Yin Q; Zhang M; Jiao Z; Wang S; Xu H; Shao Q
    J Cell Biochem; 2012 Dec; 113(12):3797-809. PubMed ID: 22806628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
    Yagi H; Nomura T; Nakamura K; Yamazaki S; Kitawaki T; Hori S; Maeda M; Onodera M; Uchiyama T; Fujii S; Sakaguchi S
    Int Immunol; 2004 Nov; 16(11):1643-56. PubMed ID: 15466453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell regulatory mechanisms in specific immunotherapy.
    Jutel M; Akdis C
    Chem Immunol Allergy; 2008; 94():158-177. PubMed ID: 18802346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-2Rbeta links IL-2R signaling with Foxp3 expression.
    Soper DM; Kasprowicz DJ; Ziegler SF
    Eur J Immunol; 2007 Jul; 37(7):1817-26. PubMed ID: 17559173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other.
    Horwitz DA; Zheng SG; Gray JD
    Trends Immunol; 2008 Sep; 29(9):429-35. PubMed ID: 18676178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural and induced T CD4+CD25+FOXP3+ regulatory T cells.
    Chatenoud L
    Methods Mol Biol; 2011; 677():3-13. PubMed ID: 20941599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
    Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
    Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4(+) CD25(+) T regulatory cells do not transfer oral tolerance to peanut allergens in a mouse model of peanut allergy.
    Marcondes Rezende M; Hassing I; Bol-Schoenmakers M; Bleumink R; Boon L; van Bilsen J; Pieters R
    Clin Exp Allergy; 2011 Sep; 41(9):1324-33. PubMed ID: 21338425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane-bound Dickkopf-1 in Foxp3
    Chae WJ; Park JH; Henegariu O; Yilmaz S; Hao L; Bothwell ALM
    Immunology; 2017 Oct; 152(2):265-275. PubMed ID: 28556921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells.
    Hall BM; Verma ND; Tran GT; Hodgkinson SJ
    Curr Opin Immunol; 2011 Oct; 23(5):641-7. PubMed ID: 21840184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and molecular determinants for the development of natural and induced regulatory T cells.
    Yuan X; Malek TR
    Hum Immunol; 2012 Aug; 73(8):773-82. PubMed ID: 22659217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
    Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
    Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foxp3-dependent programme of regulatory T-cell differentiation.
    Gavin MA; Rasmussen JP; Fontenot JD; Vasta V; Manganiello VC; Beavo JA; Rudensky AY
    Nature; 2007 Feb; 445(7129):771-5. PubMed ID: 17220874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
    Longhi MS; Meda F; Wang P; Samyn M; Mieli-Vergani G; Vergani D; Ma Y
    Hepatology; 2008 Feb; 47(2):581-91. PubMed ID: 18220288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
    Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA
    Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of TGF-Beta in the induction of Foxp3 expression and T regulatory cell function.
    Shevach EM; Davidson TS; Huter EN; Dipaolo RA; Andersson J
    J Clin Immunol; 2008 Nov; 28(6):640-6. PubMed ID: 18810612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.